Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical e-commerce, intelligent medicine, and product tracking platform businesses in the People's Republic of China. It engages in business-to-customer (B2C) retail activities; advertisement business; and business-to-business (B2B) centralized procurement distribution business. The company also provides pharmaceutical and healthcare products through its online stores on and offline pharmacy outlets to B2C and B2B customers; marketing services; health consultation services; outsourced and value-added services to the Tmall entities; and telemedicine services. In addition, it trades in pharmaceutical products; and offers network hospital services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. The company is based in Causeway Bay, Hong Kong.

This company cross-lists their shares on a U.S. stock exchange. See the related U.S. symbol ALBHF.

7.41 HKD
As of 11/26/2021

Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Pharmaceutical Retailers
Index country:  China
Country of incorporation:  Bermuda
IPO date:  01/04/2000
Stock exchange:    Hong Kong Exchange
Exchange country:   Hong Kong
Market cap:   99,946,078,208 HKD
Current dividend yield:   0.00%
CUSIP:    G0171K101
ISIN:        BMG0171K1018
Sedol:      BRXVS60

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy